List of pharmaceutical compound number prefixes
From Self-sufficiency
This article is an orphan, as few or no other articles link to it. Please introduce links to this page from related articles; suggestions may be available. (December 2007) |
 | This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (September 2007) |
This list of pharmaceutical compound number prefixes details a drug labeling standard. Pharmaceutical companies produce a large number of compounds. The compounds are systematically numbered, such as CP-529414 (for the recently failed Pfizer experimental drug torcetrapib). In addition to the number, there are several letters (the "prefix") that usually tells which company the compound comes from. Since the pharmaceutical industry has gone through a lot of mergers and acquisitions, the original company and the current company are both listed.
Contents
A to F
- ABT - Abbott Labs
- ACP - Acadia Phamarceuticals
- ACZ - Novartis
- ADL - Adolor Corporation [1]
- AG - Agouron, now Pfizer La Jolla Labs
- AH - Amersham plc (Amersham Health)
- ALS - Alantos Pharmaceuticals, acquired by Amgen in June 2007
- ANX - Adventrx Pharmaceuticals [2]
- AMG - Amgen
- ARQ - ArQule
- ATL - Antisense Therapeutics Limited, Australia [3]
- AZD - AstraZeneca
- BMS - Bristol-Myers Squibb
- BRL - Beecham Research Labs, merged with SmithKline into SmithKline Beecham which merged into GlaxoSmithKline
- CAT - Cannasat Therapeutics Inc.
- CE - Pfizer
- CGS - Ciba Geige
- CP - Pfizer Groton. CP probably refer to the founder of the company, Charles Pfizer
- CSL - CSL Ltd, an Australian Biophamaceutical company
- DMP - DuPont Merck Pharmaceuticals, a joint venture between DuPont and Merck, turns to DuPont Pharmaceuticals in 1998
- DPC - DuPont Pharmaceuticals, acquired by Bristol-Myers Squibb in 2001
- ETC - Esperion Therapeutics, acquired by Pfizer in 2003
- FK - Fermentek
G to L
- G - Genta Inc.
- GR - GlaxoSmithKline
- GS - Gilead Sciences
- GSK - GlaxoSmithKline
- HCV - ViroPharma
- IDN - Idun pharmaceuticals, acquired by Pfizer
- ILY - Ilypsa, acquired by Amgen in 2007
- INNO - CytRx, a biotech company based in Los Angeles
- ISIS - Isis Pharmaceuticals
- JNJ - Johnson & Johnson
- KOS - Kosan Biosciences
- LY - Eli Lilly
M to S
- MCN - McNeil Laboratories, now part of Johnson & Johnson
- MEM - Memory Pharmaceuticals
- MGX - Victory Pharma (this is questionable, the letters don't make sense)
- MK - Merck
- MLN - Millennium Pharmaceuticals
- NC - Nycomed
- NCX - NicOx, a French Biotech
- NG - Neurogen Corp.
- OGX - OncoGenex
- OPC - Otsuka Pharmaceutical Co.
- PD - Parke-Davis, now Pfizer
- PF - Pfizer
- PHA - Pharmacia, now Pfizer
- R - Janssen Pharmaceutica, now part of Johnson & Johnson
- RO - Hoffmann-La Roche
- RU - Roussel Uclaf
- RWJ - R.W. Johnson Pharmaceutical Research, now part of Johnson & Johnson
- SAN - Sandoz Pharmaceuticals, now Novartis
- SB - SmithKline Beecham, now GlaxoSmithKline
- SCH - Schering-Plough
- SPI - Spectrum Pharmaceuticals Inc.
- SU - Sugen, now Pfizer
T to Z
- TAK - Takeda
- TC - Targacept Inc.
- TG - Tragara Pharmaceuticals Inc. San Diego, CA
- TKS - Thiakis Limited, a UK biotech company (acquired by Wyeth in 2008)[4].
- TM - TransMolecular, Inc. [5]
- TMC - Tibotec Pharmaceuticals
- TNP - Takeda Neosplastic Product, from Takeda Pharmaceutical Company, Japan
- TS - Taisho Pharmaceutical Co., a Japanese Pharmaceutical Company [6]
- UK - Pfizer Sandwich, UK
- VX - Vertex Pharmaceuticals
- XL - Exelexis
- XTL - XTL Biopharmaceuticals
- XU - Sandoz Pharmaceuticals, now Novartis
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />- ↑ "ADL5747". Retrieved 2008-03-19.
- ↑ "Adventrx Product List". Retrieved 2007-11-18.
- ↑ "Antisense Therapeutics Ltd Home Page". Retrieved 2008-02-20.
- ↑ "MM&M News". Retrieved 2009-02-16.
- ↑ "TransMolecular Product Pipeline". Retrieved 2007-11-18.
- ↑ "Taisho Press Release". Retrieved 2008-01-07.
